Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive Analysis of Subtype-Specific Molecular Characteristics of Colon Cancer: Specific Genes, Driver Genes, Signaling Pathways, and Immunotherapy Responses

29 Nov 2021

Abstract excerpt

Colon cancer is a complex, heterogeneous disease. The Colorectal Cancer Subtyping Consortium reported a novel classification system for colon cancer in 2015 to better understand its heterogeneity. This molecular classification system divided colon cancer into four distinct consensus molecular subtypes (CMS 1, 2, 3, and 4). However, the characteristics of different colon cancer molecular subtypes have not been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Cancer Treatments and Studies
Share to Ferroptosis and cancer prognosis
Share to Genetic factors in colorectal cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34912802
DOI: 10.3389/fcell.2021.758776

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive Analysis of Subtype-Specific Molecular Characteristics of Colon Cancer: Specific Genes, Driver Genes, Signaling Pathways, and Immunotherapy ResponsesPMID 34912802Read ↗

Identification and Validation of Immune Molecular Subtypes and Immune Landscape Based on Colon Cancer CohortSemantic proximity Read ↗

Two immune-enhanced molecular subtypes differ in inflammation, immune checkpoints, mutations, and prognostic outcome in stage I-II colonic carcinoma.Semantic proximity Read ↗

Exploration of the role of tumor mutation burden in clinical significance, immunotherapy response predictor and immune cell infiltration in colon cancerSemantic proximity Read ↗

Two immune-enhanced molecular subtypes differ in inflammation, immune checkpoints, mutations and outcome in Stage I-II colonic carcinoma.Semantic proximity Read ↗

Correlations Between Tumor Mutation Burden and Immunocyte Infiltration and Their Prognostic Value in Colon CancerSemantic proximity Read ↗

Analyzing and validating the prognostic value and mechanism of colon cancer immune microenvironmentSemantic proximity Read ↗

Multi-omics analysis of the potential of MACC1 as a biomarker and therapeutic target for colonic adenocarcinomaSemantic proximity Read ↗

Prediction of prognosis, immune microenvironment and efficacy of immunotherapy based on cell cycle genes in colon cancerSemantic proximity Read ↗

Prognostic value of tumor immune cell infiltration patterns in colon adenocarcinoma based on systematic bioinformatics analysisSemantic proximity Read ↗

Transcriptome-based identification of molecular markers related to the development and prognosis of Colon cancerSemantic proximity Read ↗

Analysis of multi-omics differences in left-side and right-side colon cancerSemantic proximity Read ↗

Colorectal Cancers: An Update on Their Molecular PathologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.